Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
City of Hope, Duarte, California UC Davis, Sacramento, California Stanford Health Care, Stanford, California Moffitt Cancer Center, Tampa, Florida Emory University, Atlanta, Georgia